학술논문
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
Document Type
Article
Author
Kumar, Shaji K ; Harrison, Simon J; Cavo, Michele; de la Rubia, Javier; Popat, Rakesh; Gasparetto, Cristina; Hungria, Vania; Salwender, Hans; Suzuki, Kenshi; Kim, Inho; Punnoose, Elizabeth A; Hong, Wan-Jen; Freise, Kevin J; Yang, Xiaoqing; Sood, Anjla; Jalaluddin, Muhammad; Ross, Jeremy A; Ward, James E; Maciag, Paulo C; Moreau, Philippe
Source
In The Lancet Oncology December 2020 21(12):1630-1642
Subject
Language
ISSN
1470-2045